Bain Capital Life Sciences Investors, LLC Portfolio Holdings

Bain Capital Life Sciences Investors, LLC

  • $557 Million
  • Q3 2024

Bain Capital Life Sciences Investors, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $557 Million distributed in 24 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $276M, Savara Inc with a value of $61.8M, Pharvaris N.V. with a value of $61.2M, Annexon, Inc. with a value of $50M, and Tango Therapeutics, Inc. with a value of $20.9M.

Examining the 13F form we can see an increase of $68.3M in the current position value, from $489M to 557M.

Bain Capital Life Sciences Investors, LLC is based out at Boston, MA

Below you can find more details about Bain Capital Life Sciences Investors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $557 Million
Healthcare: $557 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 24
  • Current Value $557 Million
  • Prior Value $489 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email